Drug Shortage Report for ZOSTAVAX II

Last updated on 2017-05-17 History
Report ID 5237
Drug Identification Number 02375516
Brand name ZOSTAVAX II
Common or Proper name (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection
Company Name MERCK CANADA INC
Active Ingredient(s) VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED
Strength(s) 19400PFU
Dosage form(s) POWDER FOR SUSPENSION
Route of administration SUBCUTANEOUS
Packaging size 1 Dose Vial
ATC code J07BK
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-05-25
Actual start date
Estimated end date 2017-06-16
Actual end date 2017-05-17
Shortage status Avoided shortage
Updated date 2017-05-17
Company comments Shortage Avoided
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-05-17 French Compare
v6 2017-05-17 English Compare
v5 2017-04-03 French Compare
v4 2017-04-03 English Compare
v3 2017-04-03 English Compare
v2 2017-04-03 English Compare
v1 2017-04-03 English Compare